Key facts
- BlackRock Portfolio Management LLC filed SCHEDULE 13G for ITEOS THERAPEUTICS INC Common Stock (ITOS).
- Disclosed ownership: 6.1%.
- Date of event: 31 Mar 2025.
BlackRock Portfolio Management LLC - 31 Mar 2025 SCHEDULE 13G Report for ITEOS THERAPEUTICS INC Common Stock (ITOS)
- Filing Manager
- BlackRock Portfolio Management LLC
- Reporting Manager
- BlackRock Portfolio Management LLC
- Security
- ITEOS THERAPEUTICS INC Common Stock
- Symbol
- ITOS
- Shares outstanding
- 38,193,885 shares
- Disclosed Ownership
- 2,329,827 shares
- Ownership
- 6.1%
- Form type
- SCHEDULE 13G
- Filing time
- 15 Apr 2025, 17:04:29 UTC
- Date of event
- 31 Mar 2025
- SEC
- View on sec.gov
Key filing fact
BlackRock Portfolio Management LLC disclosed 6.1% ownership in ITEOS THERAPEUTICS INC Common Stock (ITOS) on 31 Mar 2025.
Change
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 15 Apr 2025, 17:04.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (1)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| BlackRock Portfolio Management LLC | 6.1% | 2,329,827 | 2,013,677 | 0 | Spencer Fleming | Managing Director |
CIK / CUSIP context first